Open AccessComparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Programmed Cell Death-1 Inhibitor Therapy
Author(s) -
Bingjie Zheng,
Ji Hoon Shin,
Hailiang Li,
Yanqiong Chen,
Yuan Guo,
Meiyun Wang
Publication year - 2021
Publication title -
korean journal of radiology/korean journal of radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.08
H-Index - 57
eISSN - 2005-8330
pISSN - 1229-6929
DOI - 10.3348/kjr.2020.0404
Subject(s) - medicine , renal cell carcinoma , radiological weapon , clear cell renal cell carcinoma , response evaluation criteria in solid tumors , clear cell , radiology , oncology , chemotherapy , progressive disease
To evaluate the radiological tumor response patterns and compare the response assessments based on immune-based therapeutics Response Evaluation Criteria in Solid Tumors (iRECIST) and RECIST 1.1 in metastatic clear-cell renal cell carcinoma (mccRCC) patients treated with programmed cell death-1 (PD-1) inhibitors.